These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20620168)

  • 1. Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
    Lee BY; Bailey RR; Wiringa AE; Afriyie A; Wateska AR; Smith KJ; Zimmerman RK
    Vaccine; 2010 Aug; 28(37):5952-9. PubMed ID: 20620168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.
    Lee BY; Bacon KM; Donohue JM; Wiringa AE; Bailey RR; Zimmerman RK
    Vaccine; 2011 Mar; 29(11):2149-58. PubMed ID: 21215340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
    Verelst F; Beutels P; Hens N; Willem L
    Vaccine; 2021 Apr; 39(14):2005-2015. PubMed ID: 33632564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative value of various employer-sponsored influenza vaccination clinics.
    Zimmerman RK; Wiringa AE; Nowalk MP; Lin CJ; Rousculp MD; Mitgang EA; Lee BY
    J Occup Environ Med; 2012 Sep; 54(9):1107-17. PubMed ID: 22929797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic value of seasonal and pandemic influenza vaccination during pregnancy.
    Beigi RH; Wiringa AE; Bailey RR; Assi TM; Lee BY
    Clin Infect Dis; 2009 Dec; 49(12):1784-92. PubMed ID: 19911967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.
    Burckel E; Ashraf T; de Sousa Filho JP; Forleo Neto E; Guarino H; Yauti C; Barreto F de B; Champion L
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):563-76. PubMed ID: 10662481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.
    Pereira JA; Foisy J; Kwong JC; Heidebrecht CL; Quach S; Quan SD; Guay M; Sander B;
    BMC Health Serv Res; 2011 Sep; 11():210. PubMed ID: 21880158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly.
    Kim M; Yoo BK
    Value Health; 2015 Jul; 18(5):622-30. PubMed ID: 26297090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Workplace vaccination against influenza in Malaysia: does the employer benefit?
    Samad AH; Usul MH; Zakaria D; Ismail R; Tasset-Tisseau A; Baron-Papillon F; Follet A
    J Occup Health; 2006 Jan; 48(1):1-10. PubMed ID: 16484757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L; Roiz J; Faivre P; Reygrobellet C
    Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of pandemic influenza vaccination strategies in Singapore.
    Lee VJ; Tok MY; Chow VT; Phua KH; Ooi EE; Tambyah PA; Chen MI
    PLoS One; 2009 Sep; 4(9):e7108. PubMed ID: 19771173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccination and absenteeism among healthy working adults: a cost-benefit analysis.
    Ferro A; Bordin P; Benacchio L; Fornasiero F; Bressan V; Tralli V; Moretti F; Majori S
    Ann Ig; 2020; 32(3):234-244. PubMed ID: 32266361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
    Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
    Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of the vaccination program against seasonal and pandemic A/H1N1 influenza among customs officers in Greece.
    Mamma M; Spandidos DA
    Health Policy; 2013 Jan; 109(1):71-7. PubMed ID: 23195436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
    Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinate before the next pandemic?
    Stöhr K
    Nature; 2010 May; 465(7295):161. PubMed ID: 20463719
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
    PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computer simulation of employee vaccination to mitigate an influenza epidemic.
    Lee BY; Brown ST; Cooley PC; Zimmerman RK; Wheaton WD; Zimmer SM; Grefenstette JJ; Assi TM; Furphy TJ; Wagener DK; Burke DS
    Am J Prev Med; 2010 Mar; 38(3):247-57. PubMed ID: 20042311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective.
    Morales A; Martinez MM; Tasset-Tisseau A; Rey E; Baron-Papillon F; Follet A
    Value Health; 2004; 7(4):433-41. PubMed ID: 15449635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.